Delivery Order SPE2DB22D1017-SPE2DB25FF4VM

Award Date 2/5/25
Potential Completion Date 2/6/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens, with a ceiling value of $1,121.76 and a period of performance through November 13, 2024. It was awarded on November 12, 2024 as a firm-fixed price contract. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,187.60 contract is for the delivery of Lantus SoloStar 100 unit/mL 3mL insulin pens. The award has an ultimate completion date of February 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. The contract has a ceiling value of $5,684.43 and a period of performance through August 28, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. The contract has a firm fixed price of $2,002.83 and an ultimate completion date of April 18, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar 100 unit/ml 3ml insulin pens. The contract has a ceiling value of $4,128.50 and is a firm-fixed price delivery order, with a period of performance ending on May 31, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Lantus Solostar insulin pens. The contract has a ceiling value of $1,781.40 and a period of performance ending on September 9, 2024. The order was placed under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which has a total potential value of up to $999,999,999 through December 2025...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,672.10, is for the delivery of Lantus SoloStar 100 unit/mL 3mL insulin pens. It is a firm fixed-price contract with a completion date of January 4, 2024. The contract was not set aside for any specific business size or socioeconomic category. AmerisourceBergen holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens, with a ceiling value of $2,361.14 and an ultimate completion date of February 2, 2023. The contract type is Firm Fixed Price, and it was not set aside for any specific business category. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar insulin pens. The contract has a total ceiling value of $1,294.95 and a performance period through May 16, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to $999,999,999.00 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Lantus SoloStar 100 unit/ml 3ml insulin pens. The delivery order has a ceiling value of $1,573.08 and an ultimate completion date of August 28, 2024. The contract is a Firm Fixed Price arrangement. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies to support military treatment facilities and federal healthcare providers...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF4VM
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus SoloStar 100 unit/mL 3mL insulin pens. The contract has a ceiling value of $1,234.85 and a completion date of February 6, 2025. It is a firm-fixed-price delivery order contract, without any set-aside designations. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/7/25, 10:02 AM